Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DASH: Aspirin Dosing in High-Risk Pregnancy
NCT06826859Phase 2Recruiting
- Sponsor
- Thomas Jefferson University
- Start
- Jun 2025
- Primary completion
- Jul 2029
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin in preeclampsia, preterm birth, sponsored by Thomas Jefferson University. Started Jun 2025; status: recruiting.
02
Drugs
aspirin
03
Conditions
preeclampsiapreterm birth
Beyond the preview
Go deeper on NCT06826859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06826859.